How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Orysastrobin Market
- By Formulation Type: Wettable Powder (WP), Suspension Concentrate (SC), Emulsifiable Concentrate (EC), Granules (GR), Water Dispersible Granules (WDG)
- By Application Method: Foliar Spray, Seed Treatment, Soil Treatment, Trunk Injection
- By Target Crop: Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Turf & Ornamentals
- By Mode of Action: QoI (Quinone outside Inhibitor) Fungicide
- By End-Use Industry: Agricultural, Horticultural, Turf Management
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Wettable Powder (WP) leads By Formulation Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 6 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 265 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.172 →
- 12 Company Profiles 6 players: SWOT & benchmarking p.180 →
Full report · locked preview
Everything inside the Orysastrobin Market report
A complete, evidence-based study - 12 chapters and 111 sections covering market size, segmentation across 5 axes, regional analysis and 6 company profiles, forecast to 2033.
Segmentation covered
Formulation Type 5
Application Method 4
Target Crop 4
Mode of Action 1
End-Use Industry 3
Companies profiled
BASF
Monsanto
Sumitomo
DuPont Agro
FMC
Bayer Cropscience
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
6 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Monsanto
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sumitomo
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →DuPont Agro
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.173 →FMC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →Bayer Cropscience
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.184 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,831M by 2033 · 8.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wettable Powder (WP)49.0
- Suspension Concentrate (SC)13.6
- Emulsifiable Concentrate (EC)8.9
- Granules (GR)17.0
- Water Dispersible Granules (WDG)11.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$315.4M → $538.3M · 6.9%
Europe$219.8M → $401.1M · 7.8%
Asia Pacific$200.7M → $431.4M · 10.0%
Latin America$124.3M → $214.3M · 7.0%
Middle East and Africa$95.6M → $187.0M · 8.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.432026
8.432027
8.442028
8.452029
8.462030
8.482031
8.492032
8.502033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF11.9
- Monsanto20.8
- Sumitomo6.3
- DuPont Agro13.2
- FMC11.0
- Bayer Cropscience8.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Formulation Type11.0%
Application Method26.0%
Target Crop15.8%
Mode of Action19.8%
End-Use Industry27.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.4
- Europe22.6
- Asia Pacific24.3
- Latin America12.1
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
6 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF | 98 | 76 | 91 | 80 | 75 | 77 | 83 |
| Monsanto | 86 | 77 | 93 | 89 | 90 | 87 | 87 |
| Sumitomo | 72 | 87 | 64 | 86 | 84 | 75 | 78 |
| DuPont Agro | 81 | 69 | 58 | 79 | 81 | 72 | 73 |
| FMC | 54 | 72 | 67 | 69 | 65 | 75 | 67 |
| Bayer Cropscience | 65 | 69 | 63 | 54 | 71 | 49 | 62 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF
- Monsanto
- Sumitomo
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Monsanto | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Sumitomo | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| DuPont Agro | ◐ | ◐ | − | ✓ | ✓ | ◐ |
| FMC | ◐ | ◐ | ✓ | − | − | ✓ |
| Bayer Cropscience | ◐ | ✓ | ◐ | − | ✓ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Monsanto87
2BASF83
3Sumitomo78
4DuPont Agro73
5FMC67
6Bayer Cropscience62
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
BASFMonsantoSumitomo
Challenger2
Strong scale, closing on the leaders.
DuPont AgroFMC
Contender1
Focused players with pockets of strength.
Bayer Cropscience
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Formulation Type in North America, then scale across Orysastrobin Market — a $400M beachhead inside a $7.27B market.
Beachhead (SOM)$400Mobtainable near-term
Serviceable (SAM)$2.75Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Wettable Powder (WP)
Best fit — highest urgency & budget in Formulation Type.
Economic buyer80 fit
Suspension Concentrate (SC)
Strong fit — clear ROI and a fast path to value.
End user66 fit
Emulsifiable Concentrate (EC)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Formulation Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application Method & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Crop
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Formulation Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Orysastrobin Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified20%
Evaluation12%
Closed-won7%
$14.2KCAC
$76KLTV
5.3:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Orysastrobin Market is a durable-growth opportunity — $1.06B by 2033, compounding at 8.4%.
TAM · 2025$553Mtoday
TAM · 2033$1.06Bforecast
CAGR8.4%2027–2033
Cumulative$7.03Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.06BTotal addressable market
SAM$407MServiceable available market
SOM$82MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.4% CAGR
Demand compounds through 2033, outpacing GDP across Formulation Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Formulation Type moving from early to mainstream — durable secular demand.
Consolidation upside
6+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.06BLarge & growingTAM by 2033 at 8.4% CAGR
$407MServiceable nowreachable with today’s model
$82MBeachhead winobtainable near-term share
6+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$824MBear5.5% CAGR
$1.06BBase8.4% CAGR
$1.35BBull11.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application Method optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Orysastrobin Market — a $6.65B market by 2033. Plan: grow share from 7.7% to 14.3%.
Market size · 2033$6.65Btotal addressable
Market CAGR8.5%2027–2033
Target share14.3%from 7.7% today
Revenue ambition$951Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.7% | 14.3% | Ahead |
| Revenue | $483M | $951M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 36.4% | 41.2% | On track |
| Customer retention | 87.3% | 96.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Formulation Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application Method capability
A defensible second engine — invest in Application Method to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Formulation Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application Method
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $111M capacity & capability investment
- Greenlight bolt-on M&A in Application Method
- Authorise North America expansion plan
- Fund R&D program for Formulation Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Orysastrobin Market conversation — a $8.06B market you can size, segment and defend in minutes.
Market size · 2033$8.06Btotal opportunity
Growth11.3%CAGR to 2033
Addressable buyers1,305+accounts in scope
Typical ROI7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Formulation Type
Goal Grow share in Formulation Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7×return on cost, year one
< 4 mopayback period
$63K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
6+players profiled in this market
Coverage includes
BASFMonsantoSumitomoDuPont AgroFMCBayer Cropscience
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Orysastrobin Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Orysastrobin Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Hand-held Scanners for Wound Analysis Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportHandheld Rotary Homogenizer Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportMulti-Function Infrared Thermometer Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportHand-held Resuscitator Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportHandheld Refractometers Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportHandheld Reference Thermometer Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportHandheld Red Light Therapy Device Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportHandheld Rapid Test For Concussions Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportHandheld Raman Spectroscopy Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportHandheld Raman Analyzer Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportMagnetic Stirrer Reactors Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportHandheld Radioisotope Identifiers Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.